TY - JOUR
T1 - Cardiac resynchronization therapy
T2 - What? Who? When? How?
AU - Cuculich, Phillip S.
AU - Joseph, Susan
N1 - Funding Information:
Conflict of Interest: Dr Cuculich has received research support from St. Jude Medical, serves as a research consultant for CardiaLen, Inc, and has given lectures for trainee education supported by Heart Rhythm Society and Boston Scientific.
PY - 2011/9
Y1 - 2011/9
N2 - Cardiac resynchronization therapy is an important and underused tool to help patients with heart failure symptoms, left ventricular systolic dysfunction (LVEF ≤ 35%), and intraventricular conduction system disease (QRS < 120 msec). Cardiac resynchronization therapy paces the heart simultaneously from both right and left ventricles (through the coronary sinus). Approximately three quarters of patients who undergo a successful implant will have some degree of symptomatic improvement and have fewer heart failure hospitalizations. When cardiac resynchronization therapy is combined with a defibrillator, patients may benefit from the added protection against sudden arrhythmic death.
AB - Cardiac resynchronization therapy is an important and underused tool to help patients with heart failure symptoms, left ventricular systolic dysfunction (LVEF ≤ 35%), and intraventricular conduction system disease (QRS < 120 msec). Cardiac resynchronization therapy paces the heart simultaneously from both right and left ventricles (through the coronary sinus). Approximately three quarters of patients who undergo a successful implant will have some degree of symptomatic improvement and have fewer heart failure hospitalizations. When cardiac resynchronization therapy is combined with a defibrillator, patients may benefit from the added protection against sudden arrhythmic death.
KW - Biventricular pacing
KW - Cardiac device
KW - Cardiac resynchronization therapy
KW - Heart failure
UR - http://www.scopus.com/inward/record.url?scp=80051991653&partnerID=8YFLogxK
U2 - 10.1016/j.amjmed.2010.09.028
DO - 10.1016/j.amjmed.2010.09.028
M3 - Comment/debate
C2 - 21854888
AN - SCOPUS:80051991653
SN - 0002-9343
VL - 124
SP - 813
EP - 815
JO - American Journal of Medicine
JF - American Journal of Medicine
IS - 9
ER -